Dennis Lauth

Translating 20 years of strategic and operational experience in life sciences and management consulting to build competitive commercial platforms to helping clients make significant and lasting improvements in their business performance. Specialized in commercial strategy development and execution, product launch preparedness, Operations Excellence and Restructuring/Post Merger Integration to support companies sustain profitable growth.

Leading Strategy & Business Excellence for Takeda Pharmaceuticals in EUCAN providing direction in business critical/-enabling areas: Portfolio Strategy & Opportunity Assessments, Customer Strategy & Solutions, Customer Operations Excellence, Launch Excellence, Patient Access & Services, Enabling Platforms & Services (CRM, Digital, Insights & Analytics) as well as Digital Health to provide integrated healthcare solutions with the potential to improve outcome of patients.

Headed North-/Central Europe (1300 FTEs, t/o 600+ FTEs in Commercial Operations) covering 15 countries with full P&L responsibility (> €650M sales). Provided strategic, fiscal, and operational leadership to reinvigorate growth and improve operating results of the area leading to significant enhancement of top line growth and core earnings of the area.

Reporting to Head of Marketing and Business Strategy Europe & Canada; Serve as the franchise general manager and provide overall leadership to the country brand teams in the region; Build a strong pipeline of established and future products closely cooperating with R&D to maximize the commercial opportunity of the franchise; Implement franchise and product strategies that maximize the value for the region; Define cross country initiatives and fertilize best practice sharing across the region

Lead of commercial integration for DACH countries focusing on implementation of a new operating model and streamline business support functions to better cope with the challenging healthcare environment and safeguard operating profit ratios; Member of task force to negotiate conditions and process for restructuring with works council and labor union

Managing Director of Nycomed Pharma GmbH (Marketing & Sales), Nycomed Holding GmbH (Administration) and Nycomed Austria GmbH (Manufacturing), >700 FTEs. Led the organization through the patent expiry of key revenue driver Pantoprazol, the best selling product in the Austrian market at time of exclusivity. Full P&L responsibility with net revenues around € 600m (t/o home market € 100m).

Strategy – and management consulting for midsize and multinational clients in the Life Science industry; Management of different projects such as portfolio strategy, supply chain management, working capital optimization, commercial excellence, launch readiness, innovation excellence and post‐merger integration/restructuring

Leading of the post‐merger integration of ALTANA Pharma and Nycomed Germany; Head of a cross functional integration management team (14 people); Harmonization and integration of commercial and supporting functions, supply chain and distribution; Negotiation of defined restructuring with works council and labor unions; Overachievement of integration synergy targets by effective project office and stringent execution of integration management plan

Strategic and operational management of the respiratory franchise; pre-launch preparation for a first in class respiratory treatment; Global project lead for Commercial Effectiveness and ROI improvement

Leading European Brand Team for global blockbuster with regional sales > 700 mEuro; supervising and guiding of product management teams across 30 European countries; ensure consistent and rapid implementation of core global product strategies in the different markets; facilitate experience sharing and cross fertilization; manage and track key performance indicators; Alliance management with leading pharmaceutical company